WuXi Biologics (Cayman) Inc
HKEX:2269
WuXi Biologics (Cayman) Inc
HKEX:2269
Price:
13.96 HKD
-4.12%
Market Closed
Updated:
May 4, 2024
WuXi Biologics (Cayman) Inc
Net Income (Common)
|
WuXi Biologics (Cayman) Inc
Net Income (Common) Peer Comparison
Comparables:
603259
300759
300347
1548
M
688114
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Net Income (Common)
¥3.4B
|
CAGR 3-Years
26%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
|
WuXi AppTec Co Ltd
SSE:603259
|
Net Income (Common)
¥9.6B
|
CAGR 3-Years
48%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Net Income (Common)
¥1.6B
|
CAGR 3-Years
11%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Net Income (Common)
¥2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
34%
|
CAGR 10-Years
36%
|
|
|
Genscript Biotech Corp
HKEX:1548
|
Net Income (Common)
-$95.5m
|
CAGR 3-Years
22%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
M
|
MGI Tech Co Ltd
SSE:688114
|
Net Income (Common)
¥2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is WuXi Biologics (Cayman) Inc's Net Income (Common)?
Net Income (Common)
3.4B
CNY
3.4B
CNY
Based on the financial report for Dec 31, 2023, WuXi Biologics (Cayman) Inc's Net Income (Common) amounts to 3.4B CNY.
What is WuXi Biologics (Cayman) Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
40%
40%
Over the last year, the Net Income (Common) growth was -23%. The average annual Net Income (Common) growth rates for WuXi Biologics (Cayman) Inc have been 26% over the past three years , 40% over the past five years .
You don't have any saved screeners yet
